Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pronamee Borah

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Hematology, Transfusion and Cell Therapy|September 27, 2024
Bortezomib and low dose venetoclax therapy for relapsed/refractory B-cell acute lymphoblastic leukemia with IDH1 mutationPronamee Borah, Ayoniza Maitri, Rahul Naithani
Journal of Pediatric Hematology/Oncology|April 7, 2023
Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic LeukemiaPronamee Borah, Nitin Dayal, Sangeeta Pathak, et al.
Annals of Hematology|August 9, 2023
Daratumumab-a novel treatment strategy in relapsed/refractory acute leukemiaPronamee Borah, Nitin Dayal, Sangeeta Pathak, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 20, 2020
Primary Cardiac LymphomaPronamee Borah, Preethi Jeyaraman, Sumeet Sethi, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 6, 2020
Adequate Engraftment With Lower Hematopoietic Stem Cell DosePreethi Jeyaraman, Pronamee Borah, Nitin Dayal, et al.
Blood Research|April 11, 2025
Very low-dose vemurafenib maintenance for cardiac Erdheim Chester diseaseAbhijeet Kumar Agrawal, Pronamee Borah, P D Rath, et al.
South Asian Journal of Cancer|December 25, 2025
Acute Lymphoblastic Leukemia at Birth with KMT2A Gene RearrangementSanjeev Kumar Jha, Varun Vij, Pronamee Borah, et al.
Pediatric Blood & Cancer|April 5, 2023
Daratumumab-induced minimal residual disease negative remission in CD38 (dim)-positive pediatric acute myeloid leukemiaPronamee Borah, Ng Dinah, Nitin Dayal, et al.
Blood Cell Therapy|March 10, 2025
Fecal Microbiota Transplantation for Refractory <i>Clostridioides difficile</i> Infection Post Haploidentical Transplant for Pediatric Acute Myeloid LeukemiaPronamee Borah, Vipul Gautam, Vikram Kumar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 21, 2025
Inotuzumab Ozogamicin in Indian Patients with B-Cell Acute Lymphoblastic LeukemiaPronamee Borah, Vivek Mohan, Sachin Jain, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hematology, Transfusion and Cell Therapy|September 27, 2024
Bortezomib and low dose venetoclax therapy for relapsed/refractory B-cell acute lymphoblastic leukemia with IDH1 mutationPronamee Borah, Ayoniza Maitri, Rahul Naithani
Journal of Pediatric Hematology/Oncology|April 7, 2023
Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic LeukemiaPronamee Borah, Nitin Dayal, Sangeeta Pathak, et al.
Annals of Hematology|August 9, 2023
Daratumumab-a novel treatment strategy in relapsed/refractory acute leukemiaPronamee Borah, Nitin Dayal, Sangeeta Pathak, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 20, 2020
Primary Cardiac LymphomaPronamee Borah, Preethi Jeyaraman, Sumeet Sethi, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 6, 2020
Adequate Engraftment With Lower Hematopoietic Stem Cell DosePreethi Jeyaraman, Pronamee Borah, Nitin Dayal, et al.
Blood Research|April 11, 2025
Very low-dose vemurafenib maintenance for cardiac Erdheim Chester diseaseAbhijeet Kumar Agrawal, Pronamee Borah, P D Rath, et al.
South Asian Journal of Cancer|December 25, 2025
Acute Lymphoblastic Leukemia at Birth with KMT2A Gene RearrangementSanjeev Kumar Jha, Varun Vij, Pronamee Borah, et al.
Pediatric Blood & Cancer|April 5, 2023
Daratumumab-induced minimal residual disease negative remission in CD38 (dim)-positive pediatric acute myeloid leukemiaPronamee Borah, Ng Dinah, Nitin Dayal, et al.
Blood Cell Therapy|March 10, 2025
Fecal Microbiota Transplantation for Refractory <i>Clostridioides difficile</i> Infection Post Haploidentical Transplant for Pediatric Acute Myeloid LeukemiaPronamee Borah, Vipul Gautam, Vikram Kumar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 21, 2025
Inotuzumab Ozogamicin in Indian Patients with B-Cell Acute Lymphoblastic LeukemiaPronamee Borah, Vivek Mohan, Sachin Jain, et al.
Pageof 2